TherapeuticsMD, Inc.TXMDNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank40
3Y CAGR-65.6%
5Y CAGR-43.6%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
-65.6%/yr
vs +50.5%/yr prior
5Y CAGR
-43.6%/yr
Recent deceleration
Acceleration
-116.1pp
Decelerating
Percentile
P40
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$2.80M+58.8%
2024$1.76M+35.3%
2023$1.30M-98.1%
2022$68.57M+5755.3%
2021$1.17M-97.6%
2020$48.90M+12.9%
2019$43.31M+224.1%
2018$13.36M-5.5%
2017$14.14M-6.8%
2016$15.17M-